Global MRI Safe Cardiac Resynchronization Therapy Device Market Size By Product Type (Defibrillator, Pacemaker), By Age Group (Pediatric, Geriatric), By Indication (Cardiomyopathy, Bradycardia), By Geographic Scope And Forecast

MRI Safe Cardiac Resynchronization Therapy Device Market Size And Forecast

MRI Safe Cardiac Resynchronization Therapy Device Market size is growing at a moderate pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2022 to 2030.

The rising investments and demand for invasive techniques for the treatment of heart diseases along with rising sedentary lifestyles are the major aspect driving the growth of this market. The Global MRI Safe Cardiac Resynchronization Therapy Device Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global MRI Safe Cardiac Resynchronization Therapy Device Market Definition

MRI-safe cardiac resynchronization therapy is a way to make the heart work better by making more oxygen and blood flow through the body at the same time. Cardiac resynchronization therapy devices that are safe for use with magnetic resonance imaging (MRI) are beneficial to patients suffering from heart failure syndromes such as shortness of breath, fatigue, swelling of the feet and legs, diminished appetite, exercise intolerance, depression, or who have developed arrhythmia.

Clinical studies have shown that the use of MRI-safe cardiac resynchronization therapy devices has reduced the number of hospitalizations and the rate of morbidity, as well as improved the overall quality of life for patients with the condition. Furthermore, the MRI-safe cardiac resynchronization therapy device is effective in treating patients with moderate to severe symptoms of heart failure, and the effectiveness of the therapy is comparable in men and women who receive the treatment.

The devices for cardiac resynchronization therapy that are MRI safe are implanted in the patient’s body. The pacemaker is about the size of a coin and is implanted just below the collarbone, just below the heart. The leads from the device monitor the heart rate to detect abnormal heart rate patterns and transmit small pulses to resynchronize the heart’s ventricles, according to the manufacturer. Improved heart rhythm and symptoms associated with arrhythmia are a result of the use of the therapy device.

Global MRI Safe Cardiac Resynchronization Therapy Device Market Overview

The growth drivers for the market are an increase in the prevalence rate of heart failures and other cardiac disorders along with the rise in the growth of the geriatric population who are more susceptible to illness. Over the last 30 years, the number of people who die or are disabled as a result of cardiovascular disease has steadily increased around the world external link. In just one year, the condition, which includes heart disease and stroke, was responsible for a whopping one-third of all deaths in the world, according to the latest figures. All these factors have led to growth in the market.

People are living longer worldwide. Today, the majority of people can expect to live beyond the age of sixty. Every country in the world is experiencing an increase in the population size and proportion of older people. One in six individuals on the earth will be 60 or older by 2030. The proportion of people aged 60 and older will increase from 1 billion in 2020 to 1.4 billion in 2050. The global population of people aged 60 and older will double by 2050. (2.1 billion). Between 2020 and 2050, the number of people aged 80 or older is projected to triple, reaching 426 million. The restraints for the market growth are the lack of trained and skilled professionals and the high cost of the cardiac resynchronization therapy device. Whereas the opportunities are awareness in emerging markets.

Global MRI Safe Cardiac Resynchronization Therapy Device MarketSegmentation Analysis

The Global MRI Safe Cardiac Resynchronization Therapy Device Market is Segmented on the basis of Product Type, Age Group, Indication, And Geography.

MRI Safe Cardiac Resynchronization Therapy Device Market, By Product Type

• Defibrillator• Pacemaker

Based on Product Type, The market is bifurcated into the Defibrillator and Pacemaker. The segment of defibrillators is anticipated to boost market growth due to their ability to promptly report adverse conditions and limit the death rate, as well as their superior pacing performance.

MRI Safe Cardiac Resynchronization Therapy Device Market, By Age Group

• Pediatric• Geriatric

Based on Age Group, The market is bifurcated into Pediatric and Geriatric. The geriatric segment holds the largest market share and is anticipated to continue growing due to the rise in stress, smoking, and alcohol consumption, as well as the population’s elevated risk for sudden cardiac death.

MRI Safe Cardiac Resynchronization Therapy Device Market, By Indication

• Cardiomyopathy• Bradycardia• Electrocardiography• Congestive Heart Failure

Based on Indication, The market is bifurcated into Cardiomyopathy, Bradycardia, Electrocardiography, and Congestive Heart Failure. The congestive heart failure segment is anticipated to be the market segment with the highest CAGR during the forecast period, due to the rising incidence of heart failures in older adults and the aging population.

MRI Safe Cardiac Resynchronization Therapy Device Market, By Geography

• North America• Europe• Asia Pacific• Rest of the world

On the basis of Geography, The Global MRI Safe Cardiac Resynchronization Therapy Device Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Due to an increase in cardiovascular diseases due to sedentary lifestyles, a well-established and advanced health care infrastructure, an increase in the adaptability rates of devices, and the presence of skilled and trained professionals, North America is anticipated to hold the largest market share over the forecast period.

Key Players

The “Global MRI Safe Cardiac Resynchronization Therapy Device Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Abbott, Medtronic, Boston Scientific, Cook Group, Philips, LivaNova, MicroPort Scientific, BIOTRONIK, Medico, and Qinming Medical. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In November 2021, Fujifilm Healthcare Americas Corporation introduced the Velocity MRI System, an advanced, high-field open MRI system, at the 2021 Radiological Society of North America convention (RSNA). With its unique open gantry, integrated radiofrequency (RF) coils, and reconstruction technologies, the Velocity MRI system is Fujifilm’s newest MRI scanner, designed to streamline workflow and improve the patient experience.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.